Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
about
Tau physiology and pathomechanisms in frontotemporal lobar degenerationAlzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.Inducible and reversible Clock gene expression in brain using the tTA system for the study of circadian behavior.Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.Role for glyoxalase I in Alzheimer's disease.Glial cell inclusions and the pathogenesis of neurodegenerative diseasesA53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degenerationTumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau.A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation.Modes of Aβ toxicity in Alzheimer's disease.ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice.Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease.A decade of tau transgenic animal models and beyond.Knock-out and transgenic mouse models of tauopathies.What Renders TAU ToxicAn update on the toxicity of Abeta in Alzheimer's disease.Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau.Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersOverexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration.Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.Vaccination as a therapeutic approach to Alzheimer's disease.Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.Tau and neurodegenerative disorders.Oligodendrocytes and Alzheimer's disease.Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.
P2860
Q28070250-5B827771-8154-4DE2-9D5D-881210E3D8D3Q30478477-AA10C324-7E58-4644-A431-E50E9446F107Q30480000-585E0D33-2532-4B94-B77C-9EE3D6D2C642Q33275305-D4B648CA-3329-43A7-9370-3A552C4089A3Q33876147-D0E36A33-FE44-4C2A-94E0-6AFB64E1F862Q34336935-B6FDE159-B5BE-4F72-A8EA-6EB8C4BC8236Q34538330-C9AFCD58-C345-41DB-83BD-0BB5224EC545Q34989985-C889E3F0-0FED-4D4C-B7E8-C765AE40A0B3Q35016068-A3670DB8-C26F-45E9-8A93-429EF85C5C16Q35213879-0C306411-A659-4E23-A9EE-AB057DD75D1CQ35222118-C4BA65E4-005C-47E9-B8F5-6EF22C55C112Q35235869-613D2CF2-70D1-4B61-94DF-D7C2E026C447Q35636403-48C749EF-06B0-4D88-8378-77C1E974266FQ35748867-AFC27168-461D-48A8-90EA-8CB7B2A72204Q36778845-03C74E5A-E94E-447B-99D0-858EF33E8BBCQ36817223-FFC63ED8-B116-4167-9B2D-8197A5EABF6BQ36859244-95CA35E0-8E65-4D8B-9A16-8EB652B3B244Q36914658-8F7F73A7-F9B6-4101-9C97-8C8A5F918997Q37106932-4875B8AA-4568-4AE9-A31E-9B22688B945AQ37181349-4C224CDE-6F0E-46DC-9736-49189B11F135Q37249765-212EA645-138D-4C38-8A19-D3E49D1AD8CDQ37362099-73703F5D-CF87-41E3-9D40-7E629C031536Q37630546-92351F3E-AB8B-4E9D-A654-9C276FF597BCQ37681432-A7ECF6DC-45F3-420F-B673-6EBE8F9B7C26Q38271896-9834F31F-BC69-419A-9B3F-2D85A17F4BBCQ38472413-511ADE7E-1EF6-471A-A262-92370B4374ACQ38497880-A696A26A-0050-40AF-9F28-6E7F48083707Q46747580-8890A5F2-A19D-4BED-9BA4-6EF3FF56B60CQ51154144-8876E213-E9F4-455C-9DD9-7BAFE1D81D59
P2860
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
@en
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
@nl
type
label
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
@en
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
@nl
prefLabel
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
@en
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
@nl
P2093
P2860
P1476
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
@en
P2093
P2860
P304
P356
10.1046/J.0953-816X.2001.01604.X
P407
P50
P577
2001-06-01T00:00:00Z